Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Evome Medical Technologies Inc V.EVMT

Alternate Symbol(s):  LNDZF

Evome Medical Technologies Inc. is an international medical device company, which is focused on human performance and rehabilitative solutions. The Company’s products include Biodex Rehab product, Damar Plastics product, Mio-Guard product, Simbex services, and SDP product. Its Biodex Rehab products include Isokinetic Systems, Gait Trainer, Body-Weight Supported Training, Cycles and Ergometers, and Squat-Assist Trainer. Its Mio-Guard products include bags, cases and kits, braces, and supports, diagnostics and instruments, furniture, and equipment, padding and splinting, personal protection, sanitizers and disinfectants, and tapes and wraps. Its applications include fall risk screening and conditioning, patient-driven payment model (PDPM), wellness, sports medicine solutions, neurological involvement, safe patient handling and mobility, and senior living and rehabilitation. It offers concussion, fall screening and balance assessment and training programs.


TSXV:EVMT - Post by User

Post by constructionsiteon Sep 23, 2019 10:54pm
461 Views
Post# 30157298

Inspira Financial Management Change

Inspira Financial Management Change

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.

NEW YORK, Sept. 23, 2019 (GLOBE NEWSWIRE) -- Inspira Financial Inc. (the “Company”) (TSXV:LND) today announced that Michael Dalsin has been appointed interim Chief Financial Officer of the Company. The board of directors thanks Rodrigo Mera for his tenure.

In addition, the board of directors of the Company has approved an option grant of 687,621 stock options, expiring in 5 years, to Randy Berholtz, a director of the Company, at an exercise price of $0.14 per share. All options will be subject to a four month hold. Of the options granted, one-third vest only in the event the Company makes one investment based on an introduction by Mr. Bernholtz, and another third vest only in the event the Company makes a second investment based on an introduction by Mr. Bernholtz.

The securities referred to in this news release have not been, nor will they be, registered under the United ‎States Securities Act of 1933, as amended, and may not be offered or sold within the United States or to, or for ‎the account or benefit of, U.S. persons absent U.S. registration or an applicable exemption from the U.S. ‎registration requirements. This news release does not constitute an offer for sale of securities, nor a solicitation ‎for offers to buy any securities. Any public offering of securities in the United States must be made by means of ‎a prospectus containing detailed information about the company and management, as well as financial ‎statements.‎

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in ‎the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy ‎of this release.‎

Inspira Financial Inc.
Michael Dalsin
Chairman
1 (844) 877-7562
IR@inspirafin.com
www.inspirafin.com

Bullboard Posts